Vendors are offering pilot kits to help drugmakers get a handle on the little understood business case for RFID technology. Delays in retailer and regulatory supply chain mandates have hampered adoption, says GBI Research, which forecasts annual industry growth of 34 percent through 2015, in a $3,500 report. Release